ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Willard A. Fry
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fry, W. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fry, W. A.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1998;66:1914
© 1998 The Society of Thoracic Surgeons

Invited Commentary

Willard A. Fry, MDa

a Suite 105, 2500 Ridge Ave, Evanston, IL 60201, USA

Invited commentary

These cases are where the action is, so to speak, for locoregionally advanced non–small cell lung cancer. Over the years we have, in my opinion, arrived at a consensus that proved stage IIIA non–small cell lung cancer should be considered primarily inoperable. That is particularly the case for mediastinoscopy–positive patients. To include stage . . . [Full Text of this Article]


Related Article

Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer
Thomas W. Rice, David J. Adelstein, Jay P. Ciezki, Mark E. Becker, Lisa A. Rybicki, Carol F. Farver, Marjorie A. Larto, and Eugene H. Blackstone
Ann. Thorac. Surg. 1998 66: 1909-1914. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1998 by The Society of Thoracic Surgeons.